Abstract
RAPPORT et al.1 prepared from beef serum a vasoconstrictor substance which was called ‘serotonin’. By following the pharmacological activity through various stages from serum itself to the final product, it was considered that the substance finally isolated is, in fact, that responsible for the well-known vasoconstrictor activity of serum. The latter substance, which elsewhere2 has been called ‘thrombocytin’, depends on the presence of platelets in plasma at the time of clotting3,4. For this reason we have repeated Rapport's procedure, applying it to serum prepared from highly centrifuged plasma, on one hand, and to serum prepared from platelet-rich plasma, on the other.
Similar content being viewed by others
References
Rapport, M. M., Green, A. A., and Page, J. H., J. Biol. Chem., 174, 735 (1948); 176, 1243 (1948).
Reid, G., Med. J. Aust., 2, 244 (1943).
Janeway, T. C., Richardson, H. B., and Park, A., Arch. Int. Med., 21, 565 (1918).
Reid, G., and Bick, M., Aust. J. Exp. Biol. Med. Sci., 20, 33 (1942).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
RAND, M., REID, G. Source of ‘Serotonin’ in Serum. Nature 168, 385 (1951). https://doi.org/10.1038/168385b0
Published:
Issue Date:
DOI: https://doi.org/10.1038/168385b0
- Springer Nature Limited
This article is cited by
-
Depression, Selective Serotonin Reuptake Inhibitors, and Osteoporosis
Current Osteoporosis Reports (2010)
-
Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5‐HT in the UK
British Journal of Pharmacology (2008)
-
Serotonin antagonists and vascular protection
Cardiovascular Drugs and Therapy (1990)
-
Indoleamine accumulation by retinal neurons exposed to blood
Histochemistry (1989)
-
Blood platelets and the inflammatory process
Agents and Actions (1974)